Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging.

about

Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging.

Item

http://www.wikidata.org/entity/Q55090878

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Development and validation of ...... on metabolism FDG-PET imaging.

@en

Development and validation of a novel dementia of Alzheimer's type

@nl

type

Item

label

Development and validation of ...... on metabolism FDG-PET imaging.

@en

Development and validation of a novel dementia of Alzheimer's type

@nl

prefLabel

Development and validation of ...... on metabolism FDG-PET imaging.

@en

Development and validation of a novel dementia of Alzheimer's type

@nl

P1476

Development and validation of ...... on metabolism FDG-PET imaging.

@en

P2093

Donghuan Lu

http://www.w3.org/2001/XMLSchema#string

Ian R Mackenzie

http://www.w3.org/2001/XMLSchema#string

Karteek Popuri

http://www.w3.org/2001/XMLSchema#string

Kathryn Alpert

http://www.w3.org/2001/XMLSchema#string

Lei Wang

http://www.w3.org/2001/XMLSchema#string

Mahadev Bhalla

http://www.w3.org/2001/XMLSchema#string

Mirza Faisal Beg

http://www.w3.org/2001/XMLSchema#string

Rakesh Balachandar

http://www.w3.org/2001/XMLSchema#string

Robin Ging-Yuek Hsiung

http://www.w3.org/2001/XMLSchema#string

P2860

Cortical Surface-Based Analysis

Improved optimization for the robust and accurate linear registration and motion correction of brain images

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

A novel matrix-similarity based loss function for joint regression and classification in AD diagnosis

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.

P304

802-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NICL.2018.03.007

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

P577

2018-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29876266

http://www.w3.org/2001/XMLSchema#string

P932

5988459

http://www.w3.org/2001/XMLSchema#string